ES2044853T3 - Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos. - Google Patents

Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.

Info

Publication number
ES2044853T3
ES2044853T3 ES87104601T ES87104601T ES2044853T3 ES 2044853 T3 ES2044853 T3 ES 2044853T3 ES 87104601 T ES87104601 T ES 87104601T ES 87104601 T ES87104601 T ES 87104601T ES 2044853 T3 ES2044853 T3 ES 2044853T3
Authority
ES
Spain
Prior art keywords
compounds
piridina
hidro
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87104601T
Other languages
English (en)
Inventor
Helmut Dr Schickaneder
Peter Dr Morsdorf
Armin Dr Buschauer
Walter Prof Dr Dr Schunack
Heidrun Dr Engler
Hartmut Dr Vergin
Kurt Hennings Dr Ahrens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heumann Pharma GmbH and Co
Original Assignee
Heumann Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma GmbH and Co filed Critical Heumann Pharma GmbH and Co
Application granted granted Critical
Publication of ES2044853T3 publication Critical patent/ES2044853T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN NUEVOS COMPUESTOS MEJORADORES DE LA CIRCULACION DEL CORAZON DE FORMULA GENERAL (I) QUE PUEDE EMPLEARSE PARA EL TRATAMIENTO DE ENFERMEDADES DEL CORAZON, PARA DISTINTAS FORMAS DE HIPERTONIA ASI COMO EN ENFERMEDADES DE OBTURACION ARTERIAL. ADEMAS SE DESCRIBEN PROCEDIMIENTOS PARA OBTENCION DE ESTOS COMPUESTOS Y MEDICAMENTOS QUE LOS CONTIENEN.
ES87104601T 1986-06-24 1987-03-27 Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos. Expired - Lifetime ES2044853T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863621104 DE3621104A1 (de) 1986-06-24 1986-06-24 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES2044853T3 true ES2044853T3 (es) 1994-01-16

Family

ID=6303566

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87104601T Expired - Lifetime ES2044853T3 (es) 1986-06-24 1987-03-27 Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.

Country Status (15)

Country Link
US (1) US4757080A (es)
EP (1) EP0250725B1 (es)
JP (1) JPS635089A (es)
KR (1) KR880000422A (es)
AT (1) ATE82016T1 (es)
AU (1) AU586557B2 (es)
DE (2) DE3621104A1 (es)
DK (1) DK314587A (es)
ES (1) ES2044853T3 (es)
GR (1) GR3006147T3 (es)
HU (1) HU197895B (es)
IL (1) IL82317A (es)
NZ (1) NZ220539A (es)
PT (1) PT85098B (es)
ZA (1) ZA872863B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19617606A1 (de) * 1996-05-02 1997-11-06 Wacker Chemie Gmbh Kontinuierliches Verfahren zur Herstellung lagerstabiler Organopolysiloxanzusammensetzungen
JP4898397B2 (ja) * 2006-11-21 2012-03-14 株式会社Ａｃｃｕｒａｔｅ 排水管内清掃装置及び排水管内清掃方法
WO2012069989A1 (en) * 2010-11-23 2012-05-31 Cadila Pharmaceuticals Limited Process for preparation of clevidipine and its intermediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives
DK221081A (da) * 1980-05-31 1981-12-01 Smith Kline French Lab Fremgangsmaade til fremstilling af heterocyklylalkylanidiner mellemprodukter til anvendelse ved denne fremgangsmaade og en fremgangsmaade til fremstilling af disse mellemprodukter
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
JPS60226876A (ja) * 1984-04-25 1985-11-12 Kowa Co １，４−ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
PT85098B (pt) 1990-03-30
AU7196987A (en) 1988-01-07
AU586557B2 (en) 1989-07-13
DE3782457D1 (de) 1992-12-10
GR3006147T3 (es) 1993-06-21
HUT45989A (en) 1988-09-28
ATE82016T1 (de) 1992-11-15
JPS635089A (ja) 1988-01-11
DK314587A (da) 1987-12-25
EP0250725B1 (de) 1992-11-04
IL82317A0 (en) 1987-10-30
HU197895B (en) 1989-06-28
DK314587D0 (da) 1987-06-19
KR880000422A (ko) 1988-03-25
PT85098A (de) 1987-07-01
IL82317A (en) 1991-06-10
ZA872863B (en) 1987-10-13
EP0250725A1 (de) 1988-01-07
US4757080A (en) 1988-07-12
DE3621104A1 (de) 1988-01-07
NZ220539A (en) 1989-04-26

Similar Documents

Publication Publication Date Title
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
ES519254A0 (es) Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES554305A0 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
DK418986A (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
SE8500996D0 (sv) Method of treatment
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
NO166569C (no) Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ES554115A0 (es) Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
IT8519776A0 (it) Preparato per la cura esterna delle emorroidi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 250725

Country of ref document: ES